Alivus Life Sciences Ltd (ALIVUS) Bulk Deals, Block Deals & Insider Trading
Largest bulk, block and insider deals in Alivus Life Sciences Ltd shares on NSE and BSE.
| Date | Type | Buy / Sell | Party | Quantity | Price (₹) | Value | Exchange |
|---|---|---|---|---|---|---|---|
| 04 Dec 2025 | Bulk | Buy | ICICI PRUDENTIAL MUTUAL FUND | 9,69,912 | 870 | ₹84.38 Cr | BSE |
| 15 Jul 2024 | Insider | Disposal | Glenmark Pharmaceuticals Limited · Promoter | 96,09,571 | 830.73 | ₹798.3 Cr | BSE |
| 15 Jul 2024 | Insider | Disposal | Glenn Mario Saldanha · Promoter Group | 7,800 | 829.63 | ₹0.65 Cr | BSE |
| 13 Mar 2024 | Insider | Acquisition | Nirma Limited · Promoter | 2,45,05,435 | 598.59 | ₹1,466.88 Cr | BSE |
| 13 Mar 2024 | Insider | Disposal | Glenmark Pharmaceuticals Limited · Promoter | 2,45,05,435 | 597.99 | ₹1,465.41 Cr | BSE |
| 07 Mar 2024 | Insider | Disposal | Glenmark Pharmaceuticals Limited · Promoter | 6,73,89,944 | 597.99 | ₹4,029.88 Cr | BSE |
| 25 Jan 2024 | Block | Buy | SOCIETE GENERALE | 1,51,173 | 799.55 | ₹12.09 Cr | BSE |
| 25 Jan 2024 | Block | Sell | BNP PARIBAS ARBITRAGE | 1,51,173 | 799.55 | ₹12.09 Cr | BSE |
| 25 Sept 2023 | Insider | Pledge | Glenmark Pharmaceuticals Limited · Promoter | 96,09,571 | 615 | ₹590.99 Cr | BSE |
| 17 Nov 2021 | Insider | Acquisition | GLENN SALDANHA · Promoter Group | 7,505 | 643.19 | ₹0.48 Cr | NSE |
| 17 Nov 2021 | Insider | Acquisition | GLENN SALDANHA · Promoter Group | 295 | 640.77 | ₹0.02 Cr | NSE |